MaxCyte (MXCT) has released an update.
MaxCyte, Inc. has reported that BlackRock, Inc. has altered its stake in the company, crossing a threshold on September 26, 2024, that has resulted in a combined total of 9.74% of voting rights through share ownership and financial instruments. The notification, dated September 27, 2024, indicates BlackRock’s direct voting rights in shares at 9.00%, with an additional 0.73% through financial instruments, totaling over 10 million voting rights. This change in holdings triggers a mandatory disclosure to the relevant issuer and the Financial Conduct Authority.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
